Holen Sie sich die Stockscreener-App
39.43
0.28%
-0.11
Handel nachbörslich:
39.98
0.55
+1.39%
Schlusskurs vom Vortag:
$39.54
Offen:
$39.65
24-Stunden-Volumen:
223.44K
Relative Volume:
0.80
Marktkapitalisierung:
$1.60B
Einnahmen:
$982.01M
Nettoeinkommen (Verlust:
$14.80M
KGV:
106.57
EPS:
0.37
Netto-Cashflow:
$37.02M
1W Leistung:
+5.54%
1M Leistung:
+0.69%
6M Leistung:
+31.87%
1J Leistung:
+90.67%
1-Tages-Spanne:
$38.85
$40.43
1-Wochen-Bereich:
$36.47
$40.43
52-Wochen-Spanne:
$16.16
$46.42
Phibro Animal Health Corp Stock (PAHC) Company Profile
Firmenname
Phibro Animal Health Corp
Sektor
Telefon
201-329-7300
Adresse
GLENPOINTE CENTRE EAST, 3RD FLOOR, TEANECK, NJ
Vergleichen Sie PAHC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PAHC
Phibro Animal Health Corp
|
39.43 | 1.60B | 982.01M | 14.80M | 37.02M | 0.37 |
|
ZTS
Zoetis Inc
|
125.67 | 57.00B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.90 | 49.88B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.05 | 45.73B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.40 | 36.84B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
RGC
Regencell Bioscience Holdings Ltd
|
52.88 | 16.33B | 0 | -5.87M | -767.30K | -0.45 |
Phibro Animal Health Corp Stock (PAHC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-07 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2025-06-16 | Hochstufung | BNP Paribas Exane | Underperform → Neutral |
| 2024-09-10 | Eingeleitet | JP Morgan | Neutral |
| 2023-12-07 | Eingeleitet | Exane BNP Paribas | Underperform |
| 2022-12-21 | Eingeleitet | ROTH Capital | Buy |
| 2022-07-25 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2022-01-10 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2021-11-18 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Neutral |
| 2021-07-07 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2020-08-06 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2020-02-06 | Herabstufung | Gabelli & Co | Buy → Hold |
| 2020-01-28 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2019-09-05 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2019-08-29 | Bestätigt | BofA/Merrill | Underperform |
| 2019-06-11 | Eingeleitet | Barclays | Underweight |
| 2019-05-23 | Eingeleitet | Guggenheim | Neutral |
| 2019-05-09 | Hochstufung | Gabelli & Co | Hold → Buy |
| 2017-08-23 | Fortgesetzt | BofA/Merrill | Underperform |
| 2017-06-02 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2016-12-15 | Eingeleitet | Piper Jaffray | Overweight |
| 2016-11-11 | Herabstufung | Macquarie | Neutral → Underperform |
| 2016-11-10 | Herabstufung | Gabelli & Co | Buy → Hold |
| 2016-04-11 | Bestätigt | Guggenheim | Buy |
| 2016-02-04 | Eingeleitet | Credit Suisse | Outperform |
| 2016-01-15 | Herabstufung | Barclays | Overweight → Underweight |
| 2015-09-30 | Eingeleitet | Gabelli & Co | Buy |
| 2015-04-24 | Bestätigt | Barclays | Overweight |
| 2015-04-21 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2014-05-06 | Eingeleitet | Barclays | Overweight |
Alle ansehen
Phibro Animal Health Corp Aktie (PAHC) Neueste Nachrichten
Phibro Animal Health Corporation (NASDAQ:PAHC) Receives Average Rating of “Hold” from Analysts - Defense World
Phibro Animal Health (NASDAQ:PAHC) Reports Sales Below Analyst Estimates In Q1 CY2026 Earnings - Yahoo Finance
Trend Dashboard Flags Symbiox Investment Trading Co Ltd As Potential Swing TradeDividend Stability Analysis & Free Explosive Earning Power - earlytimes.in
Phibro Animal Health Corporation (NASDAQ:PAHC) Receives Average Rating of "Hold" from Analysts - MarketBeat
Here's Why You Should Retain Glaukos Stock in Your Portfolio Now - Finviz
Reasons to Retain Baxter International Stock in Your Portfolio Now - Finviz
Is Phibro (PAHC) a Solid Growth Stock? 3 Reasons to Think "Yes" - Yahoo Finance
Phibro Animal Health (STU:PB8) EV-to-OCF : 27.56 (As of Dec. 23, 2025) - GuruFocus
Phibro Animal Health (PAHC): Assessing Valuation After a Recent Pullback and Strong Year-to-Date Rally - simplywall.st
Published on: 2025-12-21 06:36:24 - Улправда
Is Phibro Animal Health Corporation stock resilient to inflation2025 Valuation Update & Daily Profit Maximizing Trade Tips - Улправда
Phibro Animal Health (PAHC): Rethinking Valuation After a 95% Year-to-Date Surge and Recent Pullback - Yahoo Finance
Phibro Animal Health says Daniel Bendheim to assume CEO role in July - MSN
Phibro Animal Health (NASDAQ:PAHC) Shares Gap DownHere's What Happened - MarketBeat
Here's Why Phibro Animal Health (PAHC) is a Strong Value Stock - Yahoo Finance
Why hedge funds are buying Phibro Animal Health Corporation stockWeekly Gains Report & Risk Managed Investment Strategies - DonanımHaber
Is Phibro Animal Health Corporation stock a defensive play in 20252025 Breakouts & Breakdowns & Risk Adjusted Buy/Sell Alerts - DonanımHaber
Is Phibro Animal Health Corporation stock supported by strong fundamentalsTrade Volume Summary & AI Forecast Swing Trade Picks - Улправда
Phibro Animal Health Corp. Announces Leadership Transition - citybiz
Leadership Changes at Phibro Animal Health (PAHC) Aim to Drive F - GuruFocus
Phibro Animal Health announces leadership transition - Feedstuffs
Phibro Animal Health announces CEO transition effective July 2026 - Investing.com
Phibro Animal Health Names Dani Bendheim as CEO, Jack Bendheim Becomes Executive Chairman - marketscreener.com
Phibro Animal Health Corporation Announces Chief Executive Officer Changes, Effective July 1, 2026 - marketscreener.com
Phibro Animal Health (PAHC) plans CEO handoff to Dani Bendheim in 2026 - Stock Titan
Phibro Animal Health Corporation Announces Leadership Transition - Yahoo Finance
Is It Too Late to Consider Phibro After a 95% Surge in 2025? - simplywall.st
Is Phibro Animal Health Stock a Smart Addition to Your Portfolio Now? - Yahoo Finance
Best Growth Stocks to Buy for Dec. 16 - Yahoo Finance
Phibro Animal Health (PAHC) CEO details Rule 10b5-1 insider stock sales - Stock Titan
Should Value Investors Buy Phibro Animal Health (PAHC) Stock? - Yahoo Finance
Research Analysts Set Expectations for PAHC FY2026 Earnings - MarketBeat
Is Phibro Animal Health Still Attractive After a 94% Surge in 2025? - Yahoo Finance
Why is Phibro (PAHC) down 5.3% since last earnings report? - MSN
Jack Bendheim Sells 1,288 Shares of Phibro Animal Health (NASDAQ:PAHC) Stock - MarketBeat
Phibro Animal Health Corporation $PAHC Shares Bought by Arrowstreet Capital Limited Partnership - Defense World
Phibro Animal Health Stock Climbs 59.6% YTD: What's Driving It? - Finviz
Best Growth Stocks to Buy for December 9th - Yahoo Finance
Phibro (PAHC) is an Incredible Growth Stock: 3 Reasons Why - Yahoo Finance
Phibro Animal Health (NASDAQ:PAHC) CEO Sells $143,510.40 in Stock - MarketBeat
Why Is Phibro (PAHC) Down 5.3% Since Last Earnings Report? - Yahoo Finance
Is Phibro Animal Health Corporation (PB8) stock a top hedge fund pickJuly 2025 Technicals & Real-Time Stock Movement Alerts - Newser
Phibro Animal Health (PAHC): Revisiting Valuation After a Near 100% Year-to-Date Share Price Surge - Yahoo Finance
Bendheim Jack, director at Phibro, sells $288k in shares By Investing.com - Investing.com South Africa
Bendheim Jack, director at Phibro, sells $288k in shares - Investing.com
Chmn Bendheim Sells 7,040 ($288.6K) Of Phibro Animal Health Corp [PAHC] - TradingView — Track All Markets
Owner BFI Co LLC Files To Sell 316,800 Of Phibro Animal Health Corp [PAHC] - TradingView — Track All Markets
Zacks.com featured highlights include Phibro Animal Health, Argan and Ubiquiti - Yahoo Finance
Here's Why Phibro (PAHC) Could be Great Choice for a Bottom Fisher - Yahoo Finance
Here's Why Phibro Animal Health (PAHC) is a Strong Growth Stock - Yahoo Finance
Phibro Animal Health (PAHC) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Finanzdaten der Phibro Animal Health Corp-Aktie (PAHC)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.03%
2.38%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):